AGÕæÈ˹ٷ½

STOCK TITAN

Merck Commits to Veeva Vault CRM

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Veeva Systems (NYSE: VEEV) announced that Merck (NYSE: MRK) has committed to implementing Veeva Vault CRM to support their upcoming product launches across multiple therapeutic areas. The partnership expansion highlights Merck's strategic decision to leverage Vault CRM for enhanced commercial execution.

Vault CRM, part of the Vault CRM Suite, offers deep applications for commercial execution across personal and digital channels, featuring advanced global capabilities to address region-specific business and compliance requirements. This technology adoption comes at a crucial time as Merck prepares for one of its most significant launch periods in company history.

Veeva Systems (NYSE: VEEV) ha annunciato che Merck (NYSE: MRK) ha deciso di adottare Veeva Vault CRM per supportare i prossimi lanci di prodotti in diversi ambiti terapeutici. L'espansione della collaborazione sottolinea la scelta strategica di Merck di utilizzare Vault CRM per migliorare l'esecuzione commerciale.

Vault CRM, parte della Vault CRM Suite, offre applicazioni avanzate per l'esecuzione commerciale sia su canali personali che digitali, con funzionalità globali sofisticate per rispondere alle esigenze specifiche di business e conformità di ogni regione. Questa implementazione tecnologica arriva in un momento cruciale, mentre Merck si prepara a uno dei periodi di lancio più importanti nella storia dell'azienda.

Veeva Systems (NYSE: VEEV) anunció que Merck (NYSE: MRK) ha decidido implementar Veeva Vault CRM para apoyar sus próximos lanzamientos de productos en múltiples áreas terapéuticas. La ampliación de esta colaboración destaca la decisión estratégica de Merck de aprovechar Vault CRM para mejorar la ejecución comercial.

Vault CRM, parte de la suite Vault CRM, ofrece aplicaciones profundas para la ejecución comercial a través de canales personales y digitales, con capacidades globales avanzadas para atender los requisitos específicos de negocio y cumplimiento de cada región. Esta adopción tecnológica llega en un momento clave, ya que Merck se prepara para uno de los períodos de lanzamiento más importantes en la historia de la compañía.

Veeva Systems (NYSE: VEEV)µç� Merck (NYSE: MRK)ê°€ 다수ì� 치료 분야ì—서 다가오µç” 제품 출시ë¥� ì§€ì›í•˜ê¸� 위해 Veeva Vault CRM ë„ìž…ì� 확정했다ê³� 발표했습니다. ì´ë²ˆ 파트너십 í™•ìž¥ì€ Merckê°€ Vault CRMì� 활용í•� ìƒì—…ì � 실행ì� 강화하려µç� ì „ëžµì � ê²°ì •ì� 강조합니ë‹�.

Vault CRMì€ Vault CRM Suiteì� ì¼ë¶€ë¡œì„œ ê°œì¸ ë°� 디지í„� ì±„ë„ ì „ë°˜ì—� 걸친 ìƒì—…ì � 실행ì� 위한 심층 애플리케ì´ì…˜ì� 제공하며, 지역별 비즈니스 ë°� 규정 준ìˆ� 요구사항ì� 충족하µç” 고급 글로벌 기능ì� ê°–ì¶”ê³� 있습니다. ì� 기술 ë„ìž…ì€ Merckê°€ 회사 역사ìƒ� ê°€ìž� 중요í•� 출시 기간 ì¤� 하나ë¥� 준비하µç� 시ì ì—� ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.

Veeva Systems (NYSE : VEEV) a annoncé que Merck (NYSE : MRK) s'est engagé à déployer Veeva Vault CRM pour soutenir ses prochains lancements de produits dans plusieurs domaines thérapeutiques. Cette extension de partenariat souligne la décision stratégique de Merck d'exploiter Vault CRM pour une exécution commerciale renforcée.

Vault CRM, faisant partie de la suite Vault CRM, offre des applications approfondies pour l'exécution commerciale à travers des canaux personnels et digitaux, avec des capacités mondiales avancées pour répondre aux exigences spécifiques des affaires et de conformité selon les régions. Cette adoption technologique intervient à un moment crucial alors que Merck se prépare à l'une des périodes de lancement les plus importantes de son histoire.

Veeva Systems (NYSE: VEEV) gab bekannt, dass Merck (NYSE: MRK) sich verpflichtet hat, Veeva Vault CRM zur Unterstützung ihrer bevorstehenden Produkteinführungen in mehreren therapeutischen Bereichen einzusetzen. Die Erweiterung der Partnerschaft unterstreicht Mercks strategische Entscheidung, Vault CRM für eine verbesserte kommerzielle Umsetzung zu nutzen.

Vault CRM, Teil der Vault CRM Suite, bietet umfassende Anwendungen für die kommerzielle Umsetzung über persönliche und digitale Kanäle hinweg und verfügt über fortschrittliche globale Funktionen, um regionsspezifische Geschäfts- und Compliance-Anforderungen zu erfüllen. Diese Technologieeinführung erfolgt zu einem entscheidenden Zeitpunkt, da Merck sich auf eine der bedeutendsten Produkteinführungsphasen in der Unternehmensgeschichte vorbereitet.

Positive
  • Strategic partnership expansion with major pharmaceutical company Merck
  • Implementation supports Merck's significant upcoming product launch period
  • Demonstrates market validation of Veeva's Vault CRM platform
Negative
  • None.

Deep application provides foundation for commercial execution

PLEASANTON, Calif., July 21, 2025 /PRNewswire/ -- (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has committed to

The Vault CRM solution will support Merck as they enter one of the most significant launch periods in the company's history across a diverse set of new therapeutic areas and modalities.

"We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," said Dave Williams, executive vice president and chief information and digital officer at Merck. "We share a deep commitment to customer success, and Vault CRM will provide Merck the technology foundation to drive commercial execution."

"Merck has consistently been at the forefront of leading-edge science that improves the lives of millions around the world," said Veeva CEO Peter Gassner. "We are honored to be a strategic partner to Merck and it is great to see our partnership extend to Vault CRM."

Vault CRM is part of the Vault CRM Suite of deep applications that drive more effective commercial execution across personal and digital channels. With advanced global capabilities, Vault CRM Suite addresses the industry's unique regional and country-specific business and compliance requirements.Ìý

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a , Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit .

Contact:

Ìý


Maria Scurry
Veeva Systems
[email protected]

Meera Lakhani-Patel
Veeva Europe
[email protected]

Cision View original content to download multimedia:

SOURCE Veeva Systems

FAQ

What is the new partnership between Veeva Systems (NYSE: VEEV) and Merck?

Merck has committed to implementing Veeva's Vault CRM solution to support their commercial execution and upcoming product launches across multiple therapeutic areas.

Why did Merck choose Veeva Vault CRM?

Merck selected Vault CRM to provide a technology foundation for commercial execution as they enter one of the most significant launch periods in the company's history across diverse therapeutic areas and modalities.

What capabilities does Veeva's Vault CRM Suite offer?

Veeva Vault CRM Suite provides deep applications for commercial execution across personal and digital channels, with advanced global capabilities addressing region-specific business and compliance requirements.

How will this partnership affect Veeva Systems (NYSE: VEEV)?

The partnership represents a significant validation of Veeva's Vault CRM platform and expands their strategic relationship with one of the world's largest pharmaceutical companies.
Merck & Co

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Latest SEC Filings

MRK Stock Data

198.42B
2.50B
0.07%
80.53%
1.15%
Drug Manufacturers - General
Pharmaceutical Preparations
United States
RAHWAY